首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Acute and sub-chronic (28 days) oral toxicity evaluation of tincture Baccharis trimera (Less) Backer in male and female rodent animals
【24h】

Acute and sub-chronic (28 days) oral toxicity evaluation of tincture Baccharis trimera (Less) Backer in male and female rodent animals

机译:急性和亚慢性(28天)口腔毒性评估酊Baccharis Trimera(较少)的男性和女性啮齿动物动物

获取原文
获取原文并翻译 | 示例
       

摘要

The infusion of Baccharis trimera (Less) DC, popularly known as "carqueja" (broom), is popularly used in the treatment of hepatic and digestive problems. In this study, we evaluated the acute and sub-chronic oral toxicities of B. trimera tincture on male and female Wistar rats according to Organization for Economic Cooperation and Development (OECD, guidelines 423 e 407, respectively). The B. trimera tincture was administered by oral gavage in a single dose (2000 mg/kg) in doses of 100,200 and 400 mg/kg daily for 28 days. Blood was collected to analyze hematological and biochemical parameters. Kidneys and liver were homogenized to determine lipid peroxidation and delta-aminolevulinate dehydratase (delta-ALA-D) and catalase (CAT) enzyme activities. In acute treatment, tincture did not induce any signs of toxicity or mortality. Daily oral administration produced no significant changes in the hematological and biochemical parameters, except for the hepatic enzymes alanine aminotransferase (ALAT) and aspartate aminotransferase (ASAT) that showed a reduction in both sexes. Moreover, the B. trimera tincture did not increase lipid peroxidation or affected ALA-D and CAT activities. In conclusion, the tincture of B. trimera may be considered relatively safe in this protocol. (C) 2015 Elsevier Inc. All rights reserved.
机译:嗜哪种称为“Carqueja”(扫帚)的DC(较少)DC的输注普遍用于治疗肝和消化问题。在这项研究中,我们根据经济合作与发展组织(经合组织,指南423 e 407),评估了男性和女性Wistar大鼠的急性和亚慢性口腔毒性。通过每天100,200和400mg / kg的单剂量(2000mg / kg)的口服饲养剂在每天为100,200和400mg / kg,每天28天给予Trimera酊剂。收集血液以分析血液学和生化参数。肾脏和肝脏被均匀化以确定脂质过氧化和δ-氨纤维素脱水酶(Delta-Ala-D)和过氧化氢酶(猫)酶活性。在急性治疗中,酊没有诱导任何毒性或死亡的迹象。除了肝酶丙氨酸氨基氨基转移酶(Alat)和天冬氨酸氨基转移酶(ASAT)外,血液学和生化参数没有显着变化。此外,B. Trimera酊没有增加脂质过氧化或受影响的ALA-D和猫活动。总之,B. Trimera的酊剂在本协议中可能被认为是相对安全的。 (c)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号